loading
Pediatrix Medical Group Inc stock is currently priced at $9.09, with a 24-hour trading volume of 236.80K. It has seen a +2.08% increased in the last 24 hours and a -5.27% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $9.01 pivot point. If it approaches the $9.17 resistance level, significant changes may occur.
Previous Close:
$8.90
Open:
$8.85
24h Volume:
236.80K
Market Cap:
$758.75M
Revenue:
$1.99B
Net Income/Loss:
$-60.41M
P/E Ratio:
7.3449
EPS:
1.2376
Net Cash Flow:
$104.00M
1W Performance:
+0.61%
1M Performance:
-5.27%
6M Performance:
-21.88%
1Y Performance:
-35.34%
1D Range:
Value
$8.84
$9.09
52W Range:
Value
$7.70
$15.06

Pediatrix Medical Group Inc Stock (MD) Company Profile

Name
Name
Pediatrix Medical Group Inc
Name
Phone
954-384-0175
Name
Address
1301 Concord Terrace, Sunrise, FL
Name
Employee
11,825
Name
Twitter
@mednax
Name
Next Earnings Date
2024-05-09
Name
Latest SEC Filings
Name
MD's Discussions on Twitter

Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-27-21 Initiated SVB Leerink Mkt Perform
Jun-23-21 Resumed Stifel Hold
Oct-19-20 Downgrade Deutsche Bank Hold → Sell
Jan-03-20 Downgrade Citigroup Buy → Neutral
Dec-12-19 Upgrade Stifel Hold → Buy
Sep-06-19 Downgrade BofA/Merrill Neutral → Underperform
Jan-15-19 Upgrade Citigroup Neutral → Buy
Jan-03-19 Initiated Deutsche Bank Hold
Nov-16-18 Initiated UBS Sell
Sep-24-18 Upgrade Leerink Partners Mkt Perform → Outperform
Sep-18-18 Upgrade BofA/Merrill Underperform → Neutral
Aug-03-18 Upgrade Credit Suisse Neutral → Outperform
Jul-12-18 Initiated Leerink Partners Mkt Perform
Mar-27-18 Initiated Credit Suisse Neutral
Feb-12-18 Reiterated Mizuho Neutral
Dec-13-17 Initiated Piper Jaffray Overweight
Sep-18-17 Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
May-30-17 Reiterated Mizuho Neutral
May-25-17 Reiterated Stifel Hold
May-04-17 Downgrade BofA/Merrill Buy → Underperform
Mar-21-17 Downgrade Robert W. Baird Outperform → Neutral
Mar-10-17 Downgrade JP Morgan Overweight → Neutral
View All

Pediatrix Medical Group Inc Stock (MD) Financials Data

Pediatrix Medical Group Inc (MD) Revenue 2024

MD reported a revenue (TTM) of $1.99 billion for the quarter ending December 31, 2023, a +1.15% rise year-over-year.
loading

Pediatrix Medical Group Inc (MD) Net Income 2024

MD net income (TTM) was -$60.41 million for the quarter ending December 31, 2023, a -191.07% decrease year-over-year.
loading

Pediatrix Medical Group Inc (MD) Cash Flow 2024

MD recorded a free cash flow (TTM) of $104.00 million for the quarter ending December 31, 2023, a -24.22% decrease year-over-year.
loading

Pediatrix Medical Group Inc (MD) Earnings per Share 2024

MD earnings per share (TTM) was -$0.73 for the quarter ending December 31, 2023, a -191.52% decline year-over-year.
loading
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. The company also provides maternal-fetal care, including inpatient and office-based clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, its pediatric cardiology care services comprise inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it provides radiology and teleradiology services. As of December 31, 2017, the company's network consisted of approximately 4,075 affiliated physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.
$29.44
price up icon 0.53%
$117.56
price up icon 0.33%
$74.38
price up icon 1.41%
medical_care_facilities EHC
$82.78
price up icon 0.18%
medical_care_facilities CHE
$566.26
price down icon 1.08%
medical_care_facilities THC
$95.78
price down icon 1.64%
Cap:     |  Volume (24h):